Company Data
Edesa Biotech Inc.
Ticker
EDSA
Current Price
$4.2 -3.45%
Market Cap
$35.1M
Price Target
Refer to Report
Volume
4.7M
52wk Range
$0.72 - $4.35
Overview
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company’s product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company’s EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.